Nrdp1/FLRF is a ubiquitin ligase promoting ubiquitination and degradation of the epidermal growth factor receptor family member, ErbB3
- *Division of Signal Transduction, Beth Israel Deaconess Medical Center, and †Department of Cell Biology, Harvard Medical School, Boston, MA 02115
-
Communicated by Lewis Clayton Cantley, Beth Israel Deaconess Medical Center, Boston, MA (received for review March 22, 2002)
Abstract
The epidermal growth factor receptor (EGFR/ErbB) family of receptor tyrosine kinases plays fundamental roles in the regulation of cell survival, proliferation, and differentiation. Here, we present evidence that ErbB3 is degraded by proteasomes, and that Nrdp1 (referred to as FLRF in mice) associates with ErbB3 and stimulates its ubiquitination and degradation by proteasomes. Nrdp1 mRNAs are expressed in a variety of human tissues. The N-terminal half of Nrdp1 possesses an atypical RING finger domain, which is required for enhancing ErbB3 degradation. Its C-terminal half by itself associates with ErbB3 and raises ErbB3 levels in cells, probably by acting as a dominant–negative form of Nrdp1. In cell-free systems, Nrdp1 has ubiquitin ligase (E3) activity and ubiquitinates ErbB3, as well as itself, in the presence of the ubiquitin-carrier protein (E2), UbcH5. These data indicate that Nrdp1 is a RING finger-type of ubiquitin ligase, which promotes degradation of ErbB3 by proteasomes and, thus, may be an important factor influencing cell growth.
Footnotes
-
↵ ‡ To whom correspondence may be addressed at: Department of Cell Biology, Building C1–411, 240 Longwood Avenue, Harvard Medical School, Boston, MA 02115. E-mail: xqiu{at}hms.harvard.edu or Alfred_Goldberg{at}hms.harvard.edu.
- Abbreviations:
-
EGF, epidermal growth factor
-
PI, phosphatidylinositol
-
Ub, ubiquitin
-
ER, endoplasmic reticulum
-
- Copyright © 2002, The National Academy of Sciences





